Charles Schwab’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-458,248
| Closed | -$4.18M | – | 3527 |
|
|
2025
Q2 | $4.18M | Buy |
458,248
+12,070
| +3% | +$88.8K | ﹤0.01% | 2403 |
|
|
2025
Q1 | $3.55M | Sell |
446,178
-16,131
| -3% | -$118K | ﹤0.01% | 2416 |
|
|
2024
Q4 | $2.51M | Buy |
462,309
+10,116
| +2% | +$61.8K | ﹤0.01% | 2607 |
|
|
2024
Q3 | $3.26M | Buy |
452,193
+43,617
| +11% | +$399K | ﹤0.01% | 2559 |
|
|
2024
Q2 | $4.44M | Buy |
408,576
+21,437
| +6% | +$275K | ﹤0.01% | 2411 |
|
|
2024
Q1 | $7.25M | Sell |
387,139
-26,766
| -6% | -$617K | ﹤0.01% | 2149 |
|
|
2023
Q4 | $8.97M | Buy |
413,905
+4,918
| +1% | +$97.5K | ﹤0.01% | 2045 |
|
|
2023
Q3 | $8.42M | Buy |
408,987
+17,819
| +5% | +$515K | ﹤0.01% | 1999 |
|
|
2023
Q2 | $18.4M | Buy |
391,168
+5,751
| +1% | +$286K | 0.01% | 1561 |
|
|
2023
Q1 | $16.2M | Sell |
385,417
-159
| -0% | -$6.84K | ﹤0.01% | 1624 |
|
|
2022
Q4 | $14.7M | Buy |
385,576
+8,161
| +2% | +$312K | ﹤0.01% | 1639 |
|
|
2022
Q3 | $14.8M | Buy |
377,415
+7,765
| +2% | +$300K | 0.01% | 1599 |
|
|
2022
Q2 | $11.9M | Buy |
369,650
+101,705
| +38% | +$3.41M | ﹤0.01% | 1741 |
|
|
2022
Q1 | $8.87M | Buy |
267,945
+8,911
| +3% | +$335K | ﹤0.01% | 2020 |
|
|
2021
Q4 | $11M | Buy |
259,034
+3,101
| +1% | +$130K | ﹤0.01% | 1953 |
|
|
2021
Q3 | $11.3M | Sell |
255,933
-17,422
| -6% | -$799K | ﹤0.01% | 1932 |
|
|
2021
Q2 | $15.5M | Buy |
273,355
+7,283
| +3% | +$515K | 0.01% | 1759 |
|
|
2021
Q1 | $19.9M | Buy |
266,072
+6,723
| +3% | +$551K | 0.01% | 1535 |
|
|
2020
Q4 | $22.4M | Buy |
259,349
+3,460
| +1% | +$255K | 0.01% | 1319 |
|
|
2020
Q3 | $15.6M | Buy |
255,889
+2,973
| +1% | +$151K | 0.01% | 1377 |
|
|
2020
Q2 | $10.5M | Buy |
252,916
+6,982
| +3% | +$253K | 0.01% | 1617 |
|
|
2020
Q1 | $7.06M | Buy |
245,934
+4,604
| +2% | +$267K | ﹤0.01% | 1648 |
|
|
2019
Q4 | $17.4M | Buy |
241,330
+4,026
| +2% | +$495K | 0.01% | 1307 |
|
|
2019
Q3 | $33.3M | Buy |
237,304
+12,285
| +5% | +$2.06M | 0.02% | 831 |
|
|
2019
Q2 | $41.2M | Buy |
225,019
+12,134
| +6% | +$2.07M | 0.03% | 671 |
|
|
2019
Q1 | $33.9M | Buy |
212,885
+26,278
| +14% | +$3.81M | 0.02% | 776 |
|
|
2018
Q4 | $17.9M | Buy |
186,607
+9,056
| +5% | +$1.04M | 0.01% | 1063 |
|
|
2018
Q3 | $25.1M | Buy |
177,551
+6,042
| +4% | +$933K | 0.02% | 1000 |
|
|
2018
Q2 | $26.8M | Sell |
171,509
-62,436
| -27% | -$9.8M | 0.02% | 867 |
|
|
2018
Q1 | $37.7M | Buy |
233,945
+44,715
| +24% | +$7.59M | 0.03% | 613 |
|
|
2017
Q4 | $31.2M | Buy |
189,230
+38,204
| +25% | +$3.7M | 0.02% | 680 |
|
|
2017
Q3 | $9.41M | Buy |
151,026
+12,847
| +9% | +$1.01M | 0.01% | 1482 |
|
|
2017
Q2 | $11M | Buy |
138,179
+6,739
| +5% | +$487K | 0.01% | 1282 |
|
|
2017
Q1 | $9.34M | Buy |
131,440
+1,593
| +1% | +$93.3K | 0.01% | 1359 |
|
|
2016
Q4 | $6.63M | Buy |
129,847
+23,460
| +22% | +$1.11M | 0.01% | 1552 |
|
|
2016
Q3 | $4.9M | Buy |
106,387
+35,346
| +50% | +$1.44M | 0.01% | 1663 |
|
|
2016
Q2 | $2.14M | Buy |
71,041
+16,662
| +31% | +$556K | ﹤0.01% | 2042 |
|
|
2016
Q1 | $1.74M | Buy |
54,379
+14,449
| +36% | +$509K | ﹤0.01% | 2121 |
|
|
2015
Q4 | $2.33M | Buy |
39,930
+3,453
| +9% | +$171K | ﹤0.01% | 2005 |
|
|
2015
Q3 | $1.54M | Buy |
36,477
+16,582
| +83% | +$1.02M | ﹤0.01% | 2209 |
|
|
2015
Q2 | $1.45M | Buy |
19,895
+11,895
| +149% | +$765K | ﹤0.01% | 2246 |
|
|
2015
Q1 | $402K | Hold |
8,000
| – | – | ﹤0.01% | 2714 |
|
|
2014
Q4 | $293K | Buy |
+8,000
| New | +$298K | ﹤0.01% | 2850 |
|
Other funds holding SAGE
IA
HNB